These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2130785)

  • 1. Experimental studies on the interrelationship between organs mediated by peptide YY: effect on splanchnic circulation and exocrine pancreas in dogs.
    Sumi S; Inoue K; Tobe T
    Nihon Geka Hokan; 1990 May; 59(3):224-33. PubMed ID: 2130785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peptide YY on pancreatic blood flow and oxygen consumption.
    Pawlik WW; Gustaw P; Sendur R; Czarnobilski K; Hottenstein OD; Konturek SJ
    Pol J Pharmacol Pharm; 1992; 44(3):289-98. PubMed ID: 1470566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide YY inhibits pancreatic secretion via cholinergic pathways.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    J Surg Res; 1993 Jul; 55(1):103-8. PubMed ID: 8105149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of natural peptide YY on blood flow and exocrine secretion of pancreas in dogs.
    Inoue K; Hosotani R; Tatemoto K; Yajima H; Tobe T
    Dig Dis Sci; 1988 Jul; 33(7):828-32. PubMed ID: 3378477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intraluminal peptide YY on pancreatic function.
    Brodish RJ; Kuvshinoff BW; Fink AS; McFadden DW
    Int J Pancreatol; 1992 Oct; 12(2):153-60. PubMed ID: 1460330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide YY-induced inhibition of pancreatic exocrine secretion is not neurally mediated.
    DeMar AR; Meyer JH; Taylor IL; Fink AS
    Curr Surg; 1989; 46(1):10-3. PubMed ID: 2721231
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of pancreatic polypeptide and peptide YY on pancreatic blood flow and pancreatic exocrine secretion in the anesthetized dog.
    DeMar AR; Lake R; Fink AS
    Pancreas; 1991 Jan; 6(1):9-14. PubMed ID: 1994383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide YY inhibits pancreatic secretion by inhibiting cholecystokinin release in the dog.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Thompson JC
    Gastroenterology; 1988 Jan; 94(1):137-44. PubMed ID: 3335285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic polypeptide and peptide YY inhibit the denervated canine pancreas.
    DeMar AR; Taylor IL; Fink AS
    Pancreas; 1991 Jul; 6(4):419-26. PubMed ID: 1876598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide YY inhibits cholecystokinin-stimulated sphincter of Oddi activity in the prairie dog.
    Grace PA; Couse NF; Taylor IL; Pitt HA
    Surgery; 1988 Sep; 104(3):546-52. PubMed ID: 3413683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of secretin and vasoactive intestinal peptide on pancreatic secretion in dogs.
    Konturek SJ; Thor P; Dembinski A; Krol R
    Gastroenterology; 1975 Jun; 68(6):1527-35. PubMed ID: 1132634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of canine exocrine pancreatic secretion by peptide YY is mediated by PYY-preferring Y2 receptors.
    Teyssen S; Grandt D; Niebergall-Roth E; Schimiczek M; Goebell H; Eysselein VE; Reeve JR; Singer MV
    Pancreas; 1996 Jul; 13(1):80-8. PubMed ID: 8783338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic pathways do not mediate peptide YY-induced inhibition of pancreatic exocrine secretion.
    Brodish RJ; Kuvshinoff BW; McFadden DW; Fink AS
    Pancreas; 1995 Mar; 10(2):187-93. PubMed ID: 7716143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of natural peptide YY on pancreatic secretion and cholecystokinin release in conscious dogs.
    Hosotani R; Inoue K; Kogire M; Tatemoto K; Mutt V; Suzuki T; Rayford PL; Tobe T
    Dig Dis Sci; 1989 Mar; 34(3):468-73. PubMed ID: 2920652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY inhibits nutrient-, hormonal-, and vagally-stimulated pancreatic exocrine secretion.
    Lluis F; Gomez G; Fujimura M; Greeley GH; Thompson JC
    Pancreas; 1987; 2(4):454-62. PubMed ID: 3628240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenergic pathway in the inhibition of pancreatic secretion by peptide YY in dogs.
    Konturek SJ; Bilski J; Pawlik W; Tasler J; Domschke W
    Gastroenterology; 1988 Feb; 94(2):266-73. PubMed ID: 3335306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide YY: a potential proabsorptive hormone for the treatment of malabsorptive disorders.
    Liu CD; Aloia T; Adrian TE; Newton TR; Bilchik AJ; Zinner MJ; Ashley SW; McFadden DW
    Am Surg; 1996 Mar; 62(3):232-6. PubMed ID: 8607584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide YY: metabolism and effect on pancreatic secretion in dogs.
    Pappas TN; Debas HT; Taylor IL
    Gastroenterology; 1985 Dec; 89(6):1387-92. PubMed ID: 3840443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of synthetic porcine neuropeptide Y (NPY) on splanchnic blood flows and exocrine pancreatic secretion in dogs.
    Sumi S; Inoue K; Kogire M; Doi R; Yun M; Kaji H; Hosotani R; Fujimura M; Uchida K; Kiyama S; Kitagawa K; Yajima H; Fujii N; Tobe T
    Dig Dis Sci; 1991 Nov; 36(11):1523-8. PubMed ID: 19160602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones.
    Guo YS; Singh P; Gomez G; Greeley GH; Thompson JC
    Gastroenterology; 1987 May; 92(5 Pt 1):1202-8. PubMed ID: 3557015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.